A Stanford-led study shows AI can accurately predict which preterm infants will suffer complications based on metabolite patterns in newborn blood samples.
Key Details
- 1AI model used dried blood spot samples from 13,536 premature infants in California, born more than 10 weeks early.
- 2Validated the algorithm on 3,299 preterm infants from Ontario, Canada.
- 3AI identified six key blood measurements, forming a metabolic health index.
- 4Combined with clinical data (gestational age, birth weight, sex, Apgar scores), the index predicted four major complications (intestinal, eye, lung, brain) with over 85% accuracy.
- 5Research published in Science Translational Medicine (DOI: 10.1126/scitranslmed.adv4942).
Why It Matters
This approach enables much more precise risk stratification for preemies, paving the way for personalized neonatal care, early intervention, and potentially reduced morbidity through targeted resource use. It represents a significant advance in applying AI to high-impact clinical prediction using routine biomedical data.
Source
EurekAlert
Related News
•EurekAlert
New VIS-Fb Nanobody Probes Transform High-Precision Cellular Imaging
Salk and Einstein researchers have developed visible-spectrum antigen-stabilizable fluorescent nanobodies (VIS-Fbs) for sharper, multi-color live-cell imaging with minimal background noise.
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.